TMCnet News

Preimplantation Genetic Testing Market to Reach $541 Million by 2022 - Analysis by Type, Technology, Products & Services, Application, End User - Research and Markets
[July 19, 2017]

Preimplantation Genetic Testing Market to Reach $541 Million by 2022 - Analysis by Type, Technology, Products & Services, Application, End User - Research and Markets


The "Preimplantation Genetic Testing Market - Forecast to 2022" report has been added to Research and Markets' offering.

The global preimplantation genetic testing market is expected to reach USD 541.8 million by 2022 from USD 336.4 million in 2017, at a CAGR of 10.0%.

Growing rate of infertility across the globe, increasing public-private investments in the field of preimplantation genetic testing, rising number of fertility clinics worldwide, technological advancements in the field of genetic analysis, and high risk of chromosomal abnormalities in the fetus with increasing maternal age are some of the key factors driving the growth of this market. However, the high procedural cost associated with preimplantation genetic testing and unsupportive government regulations are the factors restraining the growth of this market

By technology, the preimplantation genetic testing market covers next-generation sequencing (NGS), polymerase chain reaction (PCR (News - Alert)), fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), and single-nucleotide polymorphism (SNP). The NGS segment is expected to grow at the hihest CAGR during 2017 to 2022, owing to benefits like reduced cost, better ability to detect an embryo with differing results (mosaicism), enhanced detection of structural abnormalities such as chromosomes with missing or duplicate segments, and reduction in human errors due to increased automation.



Companies Mentioned

  • Abbott Laboratories
  • Agilent (News - Alert) Technologies, Inc.
  • Beijing Genomics Institute
  • Combimatrix Corporation
  • Coopersurgical, Inc. (A Subsidiary of the Cooper Companies, Inc.)
  • Genea Limited
  • Good Start Genetics, Inc.
  • Illumina, Inc.
  • Invicta Genetics
  • Natera, Inc.
  • Oxford Gene Technology
  • Perkinelmer, Inc.
  • Progenesis
  • Rubicon Genomics (A Subsidiary of Takara Bio Usa Holdings, Inc.)
  • Scigene
  • Thermo Fisher Scientific Inc.
  • Yikon Genomics

Key Topics Covered:


1 Introduction

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Preimplantation Genetic Testing Market: Overview

6 Industry Insights

7 Preimplantation Genetic Diagnosis and Screening Market, By Procedure Type

8 Preimplantation Genetic Diagnosis and Screening Market, By Technology

9 Preimplantation Genetic Diagnosis and Screening Market, By Product and Service

10 Preimplantation Genetic Diagnosis and Screening Market, By Application

11 Preimplantation Genetic Diagnosis and Screening Market, By End User

12 Preimplantation Genetic Diagnosis and Screening Market, By Region

13 Preimplantation Genetic Testing Market: Competitive Landscape

14 Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/5t7zmx/preimplantation


[ Back To TMCnet.com's Homepage ]